Merck, South Korea's Hanwha To Co-develop Biosimilar Candidate RTT News anti-TNF compound is a drug indicated for the treatment of autoimmune diseases like rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. In northbound America, etanercept is co-marketed by Amgen, Inc. (AMGN: News ... and more » Link To Article
No comments:
Post a Comment